查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1534397

心臟再同步治療 (CRT) 設備市場：全球市場規模、佔有率、趨勢分析、機會、預測報告，2019-2030 年

Cardiac Resynchronization Therapy Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product Type; By Age; By End Use; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

心臟再同步治療 (CRT) 設備的全球市場規模正以 8.4% 的複合年成長率快速成長，到 2030 年將達到 116 億美元

由於心臟衰竭的流行、設備技術的進步、人口老化和意識的提高，全球心臟再同步治療 (CRT) 設備的使用量不斷增加，因此全球心臟再同步治療 (CRT) 設備市場正在不斷成長。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計， 以金額為準65.9 億美元。 BlueWeave 預測，在 2024 年至 2030 年的預測期內，心臟再同步治療 (CRT) 設備的全球市場規模將以 8.4% 的複合年成長率成長，到 2030 年達到 115.9 億美元。心臟衰竭和心臟疾病負擔日益增加、人口老化和久坐的生活方式推動了心臟再同步治療 (CRT) 設備的全球市場。世界人口正在迅速老化，導致出生率下降和預期壽命延長。由於人口老化，心血管疾病和心臟衰竭的增加將增加對 CRT 的需求，並在分析期間推動市場成長。

機會 - 在醫療保健領域更多地採用巨量資料

隨著主要醫療保健公司採取積極措施，心臟再同步治療 (CRT) 設備的全球市場正在蓬勃發展。這些措施包括加速產品開發、市場開拓和改善患者治療效果。領先公司專注於先進技術，為心臟病患者開發突破性產品。我們也與醫療保健提供者和學術機構合作進行臨床研究。這些公司正在透過策略聯盟和行銷努力擴大其市場佔有率，以改善全球患者對 CRT 設備的使用並推動市場成長。

地緣政治緊張局勢加劇對全球心臟再同步治療 (CRT) 設備市場的影響

地區之間不斷升級的地緣政治緊張局勢正在擾亂供應鏈、影響關鍵技術的貿易限制、外匯不穩定導致的成本增加、研發投資不確定性導致的創新放緩，以及破壞醫療基礎設施，這將影響全球心臟再同步治療(CRT) 設備市場。

心臟再同步治療 (CRT) 設備的全球市場

按細分市場分類的覆蓋範圍

心臟再同步治療 (CRT) 設備的全球市場 – 依產品類型

依產品類型分類，全球心臟再同步治療 (CRT) 設備市場分為 CRT心律調節器和 CRT心臟去顫器(CRT-D)。 CRT-D 設備在市場上佔據主導地位。 CRT-D 設備可同步心律並提供去心房顫動電擊。 CRT-D具有雙重功能，是高風險患者的首選。技術進步（例如電池壽命的延長）正在推動廣泛採用。儘管 CRT-D 設備昂貴且複雜，但它擁有很大的市場佔有率，因為它們在嚴重的心臟疾病中發揮著重要作用。

心臟再同步治療 (CRT) 設備的全球市場 - 按年齡

依年齡分類，全球心臟再同步治療 (CRT) 設備市場分為 44 歲及以下、45-64 歲、65-84 歲及 85 歲以上。 65 歲至 84 歲之間的人群主導著全球 CRT 機市場，因為他們患有與心臟相關的疾病最多。已開發國家人口老化，心血管疾病往往隨著老齡化的成長而增加。這個年齡層的人獲得醫療保健的機會促進了 CRT 設備的普及，影響了市場動態，並鼓勵製造商專注於為老年患者量身定做的創新。

競爭格局

全球心臟再同步治療（CRT）設備市場競爭激烈。市場主要企業包括美敦力、雅培、波士頓科學公司、百多力、微創科學公司、Livanova plc、Integer Holdings Corporation、樂普醫療科技有限公司、梅奧診所、Osypka Medical等。這些公司正在增加對研發活動、併購、收購、合資、聯盟、授權合約、新產品的投資，並採用各種策略，包括服務發布。

該報告的詳細分析提供了有關全球心臟再同步治療（CRT）設備市場的成長潛力、未來趨勢和統計數據的資訊。我們也關注推動市場總規模預測的因素。該報告致力於提供全球心臟再同步治療 (CRT) 設備市場的最新技術趨勢和產業見解，以幫助決策者做出適當的策略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

目錄

第1章 研究框架

第 2 章執行摘要

第 3 章心臟再同步治療 (CRT) 設備的全球市場洞察

  • 最終用途價值鏈分析
  • DROC分析
    • 生長促進因子
      • 心血管疾病發生率上升
      • 人口老化加劇
      • 產品技術進步
      • 發展中地區醫療基礎設施的擴大和良好的財務狀況
    • 抑制因素
      • CRT設備和植入手術的高成本
      • 嚴格監管場景
      • 病患和醫療專業人員對 CRT 的益處缺乏認知
    • 機會
      • 更多採用新技術
      • 主要公司的措施增加
      • 增加微創手術的引入
    • 任務
      • 裝置植入的複雜性
      • 與替代療法的競爭
  • 科技進步/最新趨勢
  • 法律規範
  • 波特五力分析

第4章全球心臟再同步治療（CRT）設備市場：行銷策略

第5章全球心臟再同步治療（CRT）設備市場：價格分析

第6章全球心臟再同步治療 (CRT) 設備市場：區域分析

  • 全球心臟再同步治療 (CRT) 設備市場，區域分析，2023 年
  • 2024-2030 年全球心臟再同步治療 (CRT) 設備市場吸引力分析

第7章全球心臟再同步治療（CRT）設備市場概述

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品類型
      • CRT心律心律調節器
      • CRT心臟去顫器
    • 按年齡
      • 44歲以下
      • 45-64歲
      • 65-84歲
      • 85歲以上
    • 按最終用途
      • 醫院
      • 心臟護理中心
      • 門診手術中心
      • 其他
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲（中東/非洲）

第8章北美心臟再同步治療（CRT）設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品類型
    • 按年齡
    • 按最終用途
    • 按國家/地區
      • 美國
      • 加拿大

第9章歐洲心臟再同步治療（CRT）設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品類型
    • 按年齡
    • 按最終用途
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第10章亞太心臟再同步治療（CRT）設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品類型
    • 按年齡
    • 按最終用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他國家

第11章拉丁美洲心臟再同步治療（CRT）設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品類型
    • 按年齡
    • 按最終用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第12章中東與非洲心臟再同步治療（CRT）設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品類型
    • 按年齡
    • 按最終用途
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 中東和非洲其他地區

第13章競爭格局

  • 主要企業及其產品列表
  • 2023年心臟再同步治療（CRT）設備公司全球市場佔有率分析
  • 透過管理參數進行競爭基準化分析
  • 重大策略發展（合併、收購、聯盟等）

第14章 地緣政治緊張局勢加劇對全球心臟再同步治療（CRT）設備市場的影響

第15章 公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Biotronik
  • MicroPort Scientific Corporation
  • Livanova plc
  • Integer Holdings Corporation
  • Lepu Medical Technology Co Ltd
  • Mayo Clinic
  • Osypka Medical
  • 其他主要企業

第16章 主要策略建議

第17章調查方法

簡介目錄
Product Code: BWC24471

Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030

Global Cardiac Resynchronization Therapy (CRT) Devices Market is growing due to heart failure prevalence, device tech advances, aging population, and increased awareness, boosting CRT device usage worldwide.

BlueWeave Consulting, a leading strategic consulting, and Market research firm, in its recent study, estimated the Global Cardiac Resynchronization Therapy (CRT) Devices Market size by value at USD 6.59 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Cardiac Resynchronization Therapy (CRT) Devices Market size to expand at a CAGR of 8.4% reaching a value of USD 11.59 billion in 2030. The Global Cardiac Resynchronization Therapy (CRT) Devices Market is driven by the increasing burden of heart failure and cardiac disorders, the geriatric population, and the sedentary lifestyle. The global population is aging rapidly, leading to reduced birth rates and increased life expectancy. The geriatric population's rise in cardiovascular and heart failure cases increases the demand for CRT, boosting market growth during the period in analysis.

Opportunity - Growing adoption of Big Data in healthcare

The Global Market for Cardiac Resynchronization Therapy (CRT) Devices is prospering as a result of proactive measures incorporated by major healthcare businesses. These measures include accelerating product development, broadening market reach, and improving patient outcomes. Major corporations are focused on sophisticated technologies to develop breakthrough goods for cardiac patients. They also work with healthcare providers and academic organizations on clinical research. These firms are extending their market presence through strategic collaborations and marketing activities, to improve global patient access to CRT devices and drive market growth.

Impact of Escalating Geopolitical Tensions on Global Cardiac Resynchronization Therapy (CRT) Devices Market

Intensifying geopolitical tensions across regions impact the Global Cardiac Resynchronization Therapy (CRT) Devices Market through supply chain disruptions, trade restrictions affecting essential technologies, increased costs due to unstable currency exchange rates, slowed innovation from uncertain R&D investments, and reduced market size in regions with unstable healthcare infrastructure.

Global Cardiac Resynchronization Therapy (CRT) Devices Market

Segmental Coverage

Global Cardiac Resynchronization Therapy (CRT) Devices Market - By Product Type

Based on product type, Global Cardiac Resynchronization Therapy (CRT) Devices Market is split into CRT-Pacemakers and CRT-Defibrillators segments. CRT-D devices dominate the market. CRT-D devices synchronize heart rhythm and provide life-saving defibrillation shocks. Their dual functionality is preferred for high risk patients. Advancements in technology like improved battery life increase adoption. CRT-D devices, despite being costly and complex, have a larger market share due to their critical role in severe cardiac conditions.

Global Cardiac Resynchronization Therapy (CRT) Devices Market - By Age

Based on age, the Global Cardiac Resynchronization Therapy (CRT) Devices Market is divided into Below 44 years, 45-64 years, 65-84 years, and Above 85 years segments. The 65-84 age group dominates the Global CRT Devices Market due to its high heart-related conditions. Aging populations in developed countries drive this trend as cardiovascular issues rise with age. This group's access to healthcare contributes to CRT device adoption, influencing market dynamics and prompting manufacturers to focus on tailored innovations for older patients.

Competitive Landscape

The Global Cardiac Resynchronization Therapy (CRT) Devices Market is fiercely competitive. Major companies in the market include Medtronic, Abbott, Boston Scientific Corporation, Biotronik, MicroPort Scientific Corporation, Livanova plc, Integer Holdings Corporation, Lepu Medical Technology Co., Ltd, Mayo Clinic, and Osypka Medical. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Global Cardiac Resynchronization Therapy (CRT) Devices Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Cardiac Resynchronization Therapy (CRT) Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Cardiac Resynchronization Therapy (CRT) Devices Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Cardiac Resynchronization Therapy (CRT) Devices Market Insights

  • 3.1. End Use Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising incidence of cardiovascular disorders
      • 3.2.1.2. Growing geriatric population
      • 3.2.1.3. Increasing advancements in product technology
      • 3.2.1.4. Expanding medical infrastructure and favorable financial conditions in developing regions
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of CRT devices and implantation procedures
      • 3.2.2.2. Stringent regulatory scenario
      • 3.2.2.3. Lack of awareness among patients and healthcare providers about the benefits of CRT
    • 3.2.3. Opportunities
      • 3.2.3.1. Increasing adoption of new technology
      • 3.2.3.2. Rising initiatives by major companies
      • 3.2.3.3. Increasing adoption of minimally invasive procedures
    • 3.2.4. Challenges
      • 3.2.4.1. Complexity of device implantation
      • 3.2.4.2. Competition from alternative therapies
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Marketing Strategies

5. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Pricing Analysis

6. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Geography Analysis

  • 6.1. Global Cardiac Resynchronization Therapy (CRT) Devices Market, Geographical Analysis, 2023
  • 6.2. Global Cardiac Resynchronization Therapy (CRT) Devices, Market Attractiveness Analysis, 2024-2030

7. Global Cardiac Resynchronization Therapy (CRT) Devices Market Overview

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
      • 7.2.1.1. CRT-Pacemakers
      • 7.2.1.2. CRT-Defibrillators
    • 7.2.2. By Age
      • 7.2.2.1. Below 44 years
      • 7.2.2.2. 45-64 years
      • 7.2.2.3. 65-84 years
      • 7.2.2.4. Above 85 years
    • 7.2.3. By End Use
      • 7.2.3.1. Hospitals
      • 7.2.3.2. Cardiac care centers
      • 7.2.3.3. Ambulatory surgical centers
      • 7.2.3.4. Others
    • 7.2.4. By Region
      • 7.2.4.1. North America
      • 7.2.4.2. Europe
      • 7.2.4.3. Asia Pacific (APAC)
      • 7.2.4.4. Latin America (LATAM)
      • 7.2.4.5. Middle East and Africa (MEA)

8. North America Cardiac Resynchronization Therapy (CRT) Devices Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Age
    • 8.2.3. By End Use
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.1.1. By Product Type
      • 8.2.4.1.2. By Age
      • 8.2.4.1.3. By End Use
      • 8.2.4.2. Canada
      • 8.2.4.2.1. By Product Type
      • 8.2.4.2.2. By Age
      • 8.2.4.2.3. By End Use

9. Europe Cardiac Resynchronization Therapy (CRT) Devices Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Age
    • 9.2.3. By End Use
    • 9.2.4. By Country
      • 9.2.4.1. Germany
      • 9.2.4.1.1. By Product Type
      • 9.2.4.1.2. By Age
      • 9.2.4.1.3. By End Use
      • 9.2.4.2. United Kingdom
      • 9.2.4.2.1. By Product Type
      • 9.2.4.2.2. By Age
      • 9.2.4.2.3. By End Use
      • 9.2.4.3. Italy
      • 9.2.4.3.1. By Product Type
      • 9.2.4.3.2. By Age
      • 9.2.4.3.3. By End Use
      • 9.2.4.4. France
      • 9.2.4.4.1. By Product Type
      • 9.2.4.4.2. By Age
      • 9.2.4.4.3. By End Use
      • 9.2.4.5. Spain
      • 9.2.4.5.1. By Product Type
      • 9.2.4.5.2. By Age
      • 9.2.4.5.3. By End Use
      • 9.2.4.6. Belgium
      • 9.2.4.6.1. By Product Type
      • 9.2.4.6.2. By Age
      • 9.2.4.6.3. By End Use
      • 9.2.4.7. Russia
      • 9.2.4.7.1. By Product Type
      • 9.2.4.7.2. By Age
      • 9.2.4.7.3. By End Use
      • 9.2.4.8. The Netherlands
      • 9.2.4.8.1. By Product Type
      • 9.2.4.8.2. By Age
      • 9.2.4.8.3. By End Use
      • 9.2.4.9. Rest of Europe
      • 9.2.4.9.1. By Product Type
      • 9.2.4.9.2. By Age
      • 9.2.4.9.3. By End Use

10. Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Age
    • 10.2.3. By End Use
    • 10.2.4. By Country
      • 10.2.4.1. China
      • 10.2.4.1.1. By Product Type
      • 10.2.4.1.2. By Age
      • 10.2.4.1.3. By End Use
      • 10.2.4.2. India
      • 10.2.4.2.1. By Product Type
      • 10.2.4.2.2. By Age
      • 10.2.4.2.3. By End Use
      • 10.2.4.3. Japan
      • 10.2.4.3.1. By Product Type
      • 10.2.4.3.2. By Age
      • 10.2.4.3.3. By End Use
      • 10.2.4.4. South Korea
      • 10.2.4.4.1. By Product Type
      • 10.2.4.4.2. By Age
      • 10.2.4.4.3. By End Use
      • 10.2.4.5. Australia & New Zealand
      • 10.2.4.5.1. By Product Type
      • 10.2.4.5.2. By Age
      • 10.2.4.5.3. By End Use
      • 10.2.4.6. Indonesia
      • 10.2.4.6.1. By Product Type
      • 10.2.4.6.2. By Age
      • 10.2.4.6.3. By End Use
      • 10.2.4.7. Malaysia
      • 10.2.4.7.1. By Product Type
      • 10.2.4.7.2. By Age
      • 10.2.4.7.3. By End Use
      • 10.2.4.8. Singapore
      • 10.2.4.8.1. By Product Type
      • 10.2.4.8.2. By Age
      • 10.2.4.8.3. By End Use
      • 10.2.4.9. Vietnam
      • 10.2.4.9.1. By Product Type
      • 10.2.4.9.2. By Age
      • 10.2.4.9.3. By End Use
      • 10.2.4.10. Rest of APAC
      • 10.2.4.10.1. By Product Type
      • 10.2.4.10.2. By Age
      • 10.2.4.10.3. By End Use

11. Latin America Cardiac Resynchronization Therapy (CRT) Devices Market

  • 11.1. Market Size & Forecast, 2019-2030
    • 11.1.1. By Value (USD Million)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Age
    • 11.2.3. By End Use
    • 11.2.4. By Country
      • 11.2.4.1. Brazil
      • 11.2.4.1.1. By Product Type
      • 11.2.4.1.2. By Age
      • 11.2.4.1.3. By End Use
      • 11.2.4.2. Mexico
      • 11.2.4.2.1. By Product Type
      • 11.2.4.2.2. By Age
      • 11.2.4.2.3. By End Use
      • 11.2.4.3. Argentina
      • 11.2.4.3.1. By Product Type
      • 11.2.4.3.2. By Age
      • 11.2.4.3.3. By End Use
      • 11.2.4.4. Peru
      • 11.2.4.4.1. By Product Type
      • 11.2.4.4.2. By Age
      • 11.2.4.4.3. By End Use
      • 11.2.4.5. Rest of LATAM
      • 11.2.4.5.1. By Product Type
      • 11.2.4.5.2. By Age
      • 11.2.4.5.3. By End Use

12. Middle East & Africa Cardiac Resynchronization Therapy (CRT) Devices Market

  • 12.1. Market Size & Forecast, 2019-2030
    • 12.1.1. By Value (USD Million)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product Type
    • 12.2.2. By Age
    • 12.2.3. By End Use
    • 12.2.4. By Country
      • 12.2.4.1. Saudi Arabia
      • 12.2.4.1.1. By Product Type
      • 12.2.4.1.2. By Age
      • 12.2.4.1.3. By End Use
      • 12.2.4.2. UAE
      • 12.2.4.2.1. By Product Type
      • 12.2.4.2.2. By Age
      • 12.2.4.2.3. By End Use
      • 12.2.4.3. Qatar
      • 12.2.4.3.1. By Product Type
      • 12.2.4.3.2. By Age
      • 12.2.4.3.3. By End Use
      • 12.2.4.4. Kuwait
      • 12.2.4.4.1. By Product Type
      • 12.2.4.4.2. By Age
      • 12.2.4.4.3. By End Use
      • 12.2.4.5. South Africa
      • 12.2.4.5.1. By Product Type
      • 12.2.4.5.2. By Age
      • 12.2.4.5.3. By End Use
      • 12.2.4.6. Nigeria
      • 12.2.4.6.1. By Product Type
      • 12.2.4.6.2. By Age
      • 12.2.4.6.3. By End Use
      • 12.2.4.7. Algeria
      • 12.2.4.7.1. By Product Type
      • 12.2.4.7.2. By Age
      • 12.2.4.7.3. By End Use
      • 12.2.4.8. Rest of MEA
      • 12.2.4.8.1. By Product Type
      • 12.2.4.8.2. By Age
      • 12.2.4.8.3. By End Use

13. Competitive Landscape

  • 13.1. List of Key Players and Their Offerings
  • 13.2. Global Cardiac Resynchronization Therapy (CRT) Devices Company Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Cardiac Resynchronization Therapy (CRT) Devices Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Medtronic
  • 15.2. Abbott
  • 15.3. Boston Scientific Corporation
  • 15.4. Biotronik
  • 15.5. MicroPort Scientific Corporation
  • 15.6. Livanova plc
  • 15.7. Integer Holdings Corporation
  • 15.8. Lepu Medical Technology Co Ltd
  • 15.9. Mayo Clinic
  • 15.10. Osypka Medical
  • 15.11. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable